GlaxoSmithKline (GSK) has disclosed a new risk, in the Cyber Security category.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GlaxoSmithKline faces significant risks in information and cyber security, as the company and its third-party partners may struggle to maintain adequate controls and governance to protect against cyber incidents. The potential failure to safeguard GSK’s information and systems could result in harm to patients, workforce, and customers, business disruptions, loss of commercial advantage, regulatory sanctions, and reputational damage. The challenging external environment, characterized by geopolitical conflicts, digital nationalism, and advanced cyber threats, exacerbates these risks. Furthermore, the reliance on a highly connected information network and the shift to hybrid working environments increase the complexity and vulnerability of GSK’s cyber security landscape.
The average GSK stock price target is $40.42, implying -1.77% downside potential.
To learn more about GlaxoSmithKline’s risk factors, click here.